COVID Vaccination in DMT-Treated MS Patients: New Data

COVID rates after vaccination are relatively low and cases mild in patients with multiple sclerosis treated with disease-modifying therapies – but vaccine antibody response is lower with anti-CD20 therapies. Medscape Medical News…
Read More

We will be happy to hear your thoughts

Leave a Reply

Enable registration in settings - general
%d bloggers like this: